Treatments

As COVID-19 cases are on the rise in many parts of the world, now seems like a good time to review treatment options. Treatment options depend on how sick someone is. For this post, we are going to give the run down treatments for adults across the clinical spectrum of disease (from no symptoms at Read more…

While effective and generally safe, Paxlovid does have the potential for some side effects. One temporary, but particularly distasteful side effect reported is “Paxlovid mouth.” Paxlovid (Nirmatrelvir + Ritonavir) has become a household name since its March 2022 Emergency Use Authorization (EUA) approval as an at-home option to treat COVID-19. It consists of a 5 Read more…

TL;DR: The FDA gave emergency use authorization to Paxlovid, an antiviral pill, that may reduce the risk of hospitalization and death for people who have mild to moderate COVID-19 infections and are at increased risk of getting severely ill. While this is super exciting news, it is not a magic answer to stopping the pandemic. Read more…

Molnupiravir is an antiviral pill that can be used in the treatment of adults with mild to moderate COVID-19 illness who are at high risk of serious illness. It should be taken within 5 days of the first symptom and only when other antiviral treatments are not available. How does molnupiravir work? Get ready for Read more…

Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…

A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…

Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…

A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…

Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…

TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…